Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

Parant, John, Chavez-Reyes, Arturo, Little, Natalie A., Yan, Wen, Reinke, Valerie, Jochemsen, Aart G., Lozano, Guillermina·2001·Nature Genetics

DOI 10.1038/ng714

Cited by (521)

Items 301–400 of 521

Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis
Hugh Gannon, Stephen N. Jones · 2012 · Genes & Cancer
Hypoxia Activates Tumor Suppressor p53 by Inducing ATR-Chk1 Kinase Cascade-mediated Phosphorylation and Consequent 14-3-3γ Inactivation of MDMX Protein
Jun-Ho Lee, Yetao Jin, Guifen He, Shelya X. Zeng, Yunyuan V. Wang, Geoffrey M. Wahl, Hua Lu · 2012 · Journal of Biological Chemistry
Mdm4 supports DNA replication in a p53-independent fashion
Kai Wohlberedt, Ina Klusmann, Polina K. Derevyanko, Kester Mo Henningsen, Josephine Ann Mun Yee Choo, Valentina Manzini, Anna Magerhans, Celeste Giansanti, Christine M. Eischen, Aart G. Jochemsen et al. · 2020 · Oncogene
miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma
Fabian Dominik Mairinger, Robert Werner, Elena Flom, Jan Schmeller, Sabrina Borchert, Michael Wessolly, Jeremias Wohlschlaeger, Thomas Hager, Thomas Mairinger, Jens Kollmeier et al. · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Mdm2 protein Expression is Strongly Associated with Survival in Malignant Pleural Mesothelioma
Fabian Dominik Mairinger, Robert F. H. Walter, Saskia C. Ting, Claudia Vollbrecht, Jens Kollmeier, S Griff, Thomas Hager, Thomas Mairinger, Daniel Christian Christoph, Dirk Theegarten et al. · 2014 · Future Oncology
Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx
Zengxin Lu, Guohui Wan, Huarong Guo, Xinna Zhang, Xiongbin Lu · 2012 · Cellular Signalling
Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo
Elizabeth A. Slee, Barbara Benassi, Robert David Goldin, Shan Zhong, Indrika Ratnayaka, Giovanni Blandino, Xin Lü · 2010 · Proceedings of the National Academy of Sciences
Behind the scenes: Unravelling the molecular mechanisms of p53 target gene selectivity (Review)
Lohrum · 2010 · International Journal of Oncology
Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53
Zijian Li, Yue Xiong · 2017 · Oncogene
Regulation of MDM4
Michael P. Markey · 2010 · Frontiers in bioscience
Phosphorylation of MdmX by CDK2/Cdc2p34 is required for nuclear export of Mdm2
Bertha C. Elias, Aaron Michael Laine, Ze’ev A. Ronai · 2005 · Oncogene
Guilty as CHARGED: p53's expanding role in disease
Jeanine L. Van Nostrand, Laura Donatella Attardi · 2014 · Cell Cycle
Developmental Acquisition of p53 Functions
Sushil Kumar Jaiswal, Sonam Raj, Melvin Depamphilis · 2021 · Genes
Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish
Joy Shijia Chua, Hoe Peng Liew, Lin Guo, David Philip Lane · 2015 · Oncogene
Tumor suppressor p53 and estrogen receptors in nuclear–mitochondrial communication
Nadi T. Wickramasekera, Gokul M. Das · 2013 · Mitochondrion
The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Heng Jiang, Jing Luo, Hetian Lei · 2022 · Experimental Eye Research
DNAJB1 stabilizes MDM2 and contributes to cancer cell proliferation in a p53-dependent manner
Min Qi, Jianglin Zhang, Weiqi Zeng, Xiang Chen · 2013 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Peptide Activators of the p53 Tumor Suppressor
Changyou Zhan, Wuyuan Lu · 2011 · Current Pharmaceutical Design
Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein–Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy
Jing Cheng, Ziqin Yan, Kailong Jiang, Chen Liu, Dehua Xu, Xilin Lyu, Xiaobei Hu, Shiyan Zhang, Yubo Zhou, Jia Li et al. · 2023 · Journal of Medicinal Chemistry
Structural basis of how stress-induced MDMX phosphorylation activates p53
X Chen, Neelakshi Gohain, Changyou Zhan, W-Y Lu, Marzena Pazgier, Wuyuan Lu · 2015 · Oncogene
HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis
Mei Liang, Xin Han, Saroj Vadhan‐Raj, Martin H. Nguyen, Yu H. Zhang, Michael Fernandez, Elias Drakos, Sergej Naumovich Konoplev, C. Cameron Yin, Roberto N. Miranda et al. · 2010 · Modern Pathology
Overexpression of Mdm2 and MdmX Fusion Proteins Alters p53 Mediated Transactivation, Ubiquitination, and Degradation
Mithua Ghosh, Huang Keven, Steven J. Berberich · 2003 · Biochemistry
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program
Vinod Pant, Chang Sun, Guillermina Lozano · 2023 · Cell Death and Differentiation
Guardian of corpulence: a hypothesis on p53 signaling in the fat cell
Merlijn Bazuine, Karin G. Stenkula, Maggie Cam, Mathilde Arroyo, Samuel W. Cushman · 2009 · Clinical Lipidology
Mouse modelling of the MDM2/MDMX−p53 signalling axis
Nicole R. Tackmann, Yanping Zhang · 2017 · Journal of Molecular Cell Biology
MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis
Qingling Huang, Lihong Chen, Leixiang Yang, Xiaoling Xie, Lin Gan, John L. Cleveland, Jiandong Chen · 2018 · Proceedings of the National Academy of Sciences
Protecting the genome from mdm2 and mdmx
Melo, A. N., Eischen, C. M. · 2012 · Genes & Cancer
The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma
Chi–Che Hsieh, Che‐Hung Shen · 2019 · Current Treatment Options in Oncology
The ribosomal protein L22 binds the MDM4 pre-mRNA and promotes exon skipping to activate p53 upon nucleolar stress
Jennifer Jansen, Katherine E. Bohnsack, Susanne Böhlken-Fascher, Markus T. Bohnsack, Matthias Dobbelstein · 2024 · Cell Reports
Modification of MDMX by sumoylation
Yu Pan, Jiandong Chen · 2005 · Biochemical and Biophysical Research Communications
Phosphatase magnesium-dependent 1 δ (PPM1D), serine/threonine protein phosphatase and novel pharmacological target in cancer
Rita Nahta, Robert Craig Castellino · 2020 · Biochemical Pharmacology
MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.
Jin Wu, Guanting Lu, Xinjiang Wang · 2021 · PubMed Central
Mouse models of Mdm2 and Mdm4 and their clinical implications
Shunbin Xiong · 2013 · 癌症：英文版
Cell Death and the p53 Enigma During Mammalian Embryonic Development
Sonam Raj, Sushil Kumar Jaiswal, Melvin Depamphilis · 2022 · Stem Cells
The associations between MDM4 gene polymorphisms and cancer risk
Ming-Jie Wang, Yongjun Luo, Zhi-Yong Shi, Xiaoliang Xu, Guoliang Yao, Ruiping Liu, Hui Zhao · 2016 · Oncotarget
p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction
Ixaura Medina‐Medina, Mayra Martínez‐Sánchez, Jesús Hernández‐Monge, Robin Fåhræus, Petr Müller, Vanesa Olivares‐Illana · 2018 · Protein Science
Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy
Robert F. H. Walter, Claudia Vollbrecht, Robert Werner, Thomas Mairinger, Jan Schmeller, Elena Flom, Jeremias Wohlschlaeger, Nikolaos G. Barbetakis, Dimitrios Paliouras, Fotios G. Chatzinikolaou et al. · 2016 · Journal of Cancer
Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample
Mohammad Mostakhdem Hashemi, Sara Sanaei, Seyeh Mehdi Hashemi, Ebrahim Eskandari, Gholamreza Bahari · 2018 · Clinical Breast Cancer
Harnessing p53 for targeted cancer therapy: new advances and future directions
Zdeněk Andrysík, Joaquin Maximiliano Espinosa · 2025 · Transcription
MDM2 oligomers: antagonizers of the guardian of the genome
Patrick L. Leslie, Yingao Zhang · 2016 · Oncogene
Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer
MAXIMILIAN CHRISTIAN KRIEGMAIR, Matthias Balk, Ralph Markus Wirtz, Annette Steidler, Cleo‐Aron Weis, Johannes Breyer, Arndt Hartmann, Christian Bolenz, Philipp Erben · 2016 · Anticancer Research
Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
Ning Kon, Donglai Wang, Tongyuan Li, Le Jiang, Li Qiang, Wei Gu · 2018 · Oncotarget
Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells
Olga Egorova, Heather HC Lau, Kate McGraphery, Yi Sheng · 2020 · International Journal of Molecular Sciences
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection
Heng Yang, Zhi‐Ming Zheng, Lisa Zhao, Qiang Li, Daiqing Liao · 2012 · Cell Cycle
Mouse models with modified p53 sequences to study cancer and ageing
Alan Richard Clarke, Monica Hollstein · 2003 · Cell Death and Differentiation
The Acetylase Activity of p300 Is Dispensable for MDM2 Stabilization
Shelya X. Zeng, Yetao Jin, David Kuninger, Peter S. Rotwein, Hua Lu · 2003 · Journal of Biological Chemistry
Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts
Lenos, Kristiaan, de Lange, Job, Teunisse, Amina FAS, Lodder, Kirsten, Verlaan-de Vries, Matty, Wiercinska, Eliza, van der Burg, Marja JM, Szuhai, Karoly, Jochemsen, Aart G · 2011 · Molecular Cancer
Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)
Antonio Macchiarulo, Nicola Giacchè, Andrea Carotti, Fabiola Moretti, Roberto Pellicciari · 2011 · MedChemComm
microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma
Robert F. H. Walter, Claudia Vollbrecht, Robert Werner, Jeremias Wohlschlaeger, Daniel Christian Christoph, Kurt Werner Schmid, Fabian Dominik Mairinger · 2016 · Oncotarget
Interaction between p53 Mutation and a Somatic HDMX Biomarker Better Defines Metastatic Potential in Breast Cancer
Anna M. Grawenda, Elen K. Møller, Suzanne Lam, Emmanouela Repapi, Amina F.A.S. Teunisse, Grethe I.G. Alnæs, Anne‐Lise Børresen‐Dale, Vessela Nedelcheva Kristensen, Colin R. Goding, Aart G. Jochemsen et al. · 2015 · Cancer Research
Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4
Chuandong Fan, Xinjiang Wang · 2017 · Cell Cycle
Predicted Functions of MdmX in Fine-Tuning the Response of p53 to DNA Damage
Sohyoung Kim, Mirit I. Aladjem, Geoffrey B. McFadden, Kurt W. Kohn · 2010 · PLoS Computational Biology
The Central Role of Ribosomal Proteins in p53 Regulation
Mikael S. Lindström · 2025 · Cancers
Arrestins in Apoptosis
Seunghyi Kook, Vsevolod V. Gurevich, Eugenia V. Gurevich · 2013 · Handbook of experimental pharmacology
Tumorigenesis promotes Mdm4-S overexpression
Vinod Pant, Connie A. Larsson, Neeraj K. Aryal, Shunbin Xiong, Mingjian James You, Alfonso Quintás‐Cardama, Guillermina Lozano · 2017 · Oncotarget
A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize
Pavlína Kosztyu, Iva Slaninová, Barbora Valčíková, Amandine Verlande, Petr Müller, Jan Josef Palecek, Stjepan Uldrijan · 2019 · Frontiers in Physiology
The Janus Face of p53-Targeting Ubiquitin Ligases
Qian Hao, Yajie Chen, Xiang Yu Zhou · 2020 · Cells
Thymine DNA glycosylase regulates cell-cycle-driven p53 transcriptional control in pluripotent cells
Sergi Aranda, Anna Alcaine-Colet, Cecilia Ballaré, Enrique Blanco, Ivano Mocavini, Aleksandra Sparavier, Pedro Vizán, Eva Borràs, Eduard Sabidó, Luciano Di Croce · 2023 · Molecular Cell
Daxx Functions Are p53-Independent In Vivo
Amanda R. Wasylishen, Jeannelyn Santiano Estrella, Vinod Pant, Gilda P. Chau, Guillermina Lozano · 2018 · Molecular Cancer Research
The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells
Zdenka Matijašević, Anna Krzywicka-Racka, Greenfield Sluder, Jean‐Nicolas Gallant, Stephen N. Jones · 2016 · Oncogenesis
MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells
Renier C. Heijkants, Amina F.A.S. Teunisse, Daniëlle de Jong, Kseniya Glinkina, Hailiang Mei, Szymon M. Kiełbasa, Károly Szuhai, Aart G. Jochemsen · 2022 · Cancers
Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition
Andrea Carotti, Antonio Macchiarulo, Nicola Giacchè, Roberto Pellicciari · 2009 · Proteins Structure Function and Bioinformatics
Cerebellum Development and Tumorigenesis: A p53-Centric Perspective
Nicolas J. Barthelery, James J. Manfredi · 2016 · Trends in Molecular Medicine
Regulation of kidney development by the Mdm2/Mdm4–p53 axis
Samir Sayem El-Dahr, Sylvia A. Hilliard, Zubaida R. Saifudeen · 2017 · Journal of Molecular Cell Biology
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
Robert F. H. Walter, Robert Werner, Michael Wessolly, Elena Mairinger, Sabrina Borchert, Jan Schmeller, Jens Kollmeier, Thomas Mairinger, Thomas Hager, Ágnes Bánkfalvi et al. · 2018 · Journal of Oncology
A p53-Dependent Checkpoint Induced upon DNA Damage Alters Cell Fate during hiPSC Differentiation
Cara Bernadette Eldridge, Finian J. Allen, Alastair Crisp, Rodrigo A. Grandy, Ludovic Vallier, Julian E. Sale · 2020 · Stem Cell Reports
HDMX regulates p53 activity and confers chemoresistance to 3-Bis(2-chloroethyl)-1-nitrosourea
Genglin Jin, Stephen Cook, Bo Cui, William Chen, Stephen Thomas Keir, Patrick J. Killela, Chunhui Di, Cathy A. Payne, Simon G. Gregory, Roger E. McLendon et al. · 2010 · Neuro-Oncology
Variations within 3′-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy
Yang Yang, Wen Gao, Xi Ding, Wen Xu, Di Liu, Bo Su, Yifeng Sun · 2016 · Oncotarget
MDM4 genetic variants and risk of gastric cancer in an eastern chinese population
Mengyun Wang, Ming Jia, Jing He, Fei Zhou, Li‐Xin Qiu, Meng-Hong Sun, Ya-Jun Yang, Jiu-Cun Wang, Jin Li, Ya-Nong Wang et al. · 2017 · Oncotarget
Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathway
Morgane Le Bras, Karim Bensaad, Thierry Soussi · 2003 · Oncogene
Chemical modulation of transcription factors
Bianca M. Wiedemann, Jörn Weisner, Daniel Rauh · 2018 · MedChemComm
Adult progenitor rejuvenation with embryonic factors
Peng Wang, Xupeng Liu, Yu Chen, Elwin Tan Jun‐Hao, Ziyue Yao, Jason Chua Min‐Wen, Benjamin Yan-Jiang Chua, Shilin Ma, Wenwu Ma, Lanfang Luo et al. · 2023 · Cell Proliferation
Mdm2 and MdmX Involvement in Human Cancer
Steven J. Berberich · 2014 · Sub-cellular biochemistry/Subcellular biochemistry
Pathway analysis for a genome-wide association study of pneumoconiosis
Ting Wang, Jingjin Yang, Xiaoming Ji, Minjie Chu, Ruyang Zhang, Juncheng Dai, Guangfu Jin, Zhibin Hu, Hongbing Shen, Chunhui Ni · 2014 · Toxicology Letters
MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling
Qingling Huang, Lihong Chen, E. Schönbrunn, Jiandong Chen · 2020 · The EMBO Journal
MDM4 overexpression contributes to synoviocyte proliferation in patients with rheumatoid arthritis
Nanwei Xu, Yuji Wang, Dawei Li, Guoqiang Chen, Rongbin Sun, Ruixia Zhu, Sai Sun, Hongwei Liu, Guang Yang, Tianhua Dong · 2010 · Biochemical and Biophysical Research Communications
p53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte
Lin Römer, Christian Klein, Alexander Dehner, Horst Kessler, Johannes Büchner · 2006 · Angewandte Chemie
The Enigma of p53
Guillermina Lozano · 2016 · Cold Spring Harbor Symposia on Quantitative Biology
Differential requirements for MDM2 E3 activity during embryogenesis and in adult mice
Timothy J. Humpton, Koji Nomura, Julia Weber, H Magnussen, Andreas K. Hock, Colin Nixon, Sandeep Dhayade, David Stevenson, Danny T. C. Huang, Douglas Strathdee et al. · 2020 · Genes & Development
Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis
Yi-Wei Zhang, Xin Zhang, Hua Lu · 2014 · Developmental Biology
Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumors
Robert F. H. Walter, Claudia Vollbrecht, Daniel Christian Christoph, Robert Werner, Jan Schmeller, Elena Flom, Georgia Trakada, Aggeliki Rapti, Vasilis Adamidis, Wolfgang Hohenforst‐Schmidt et al. · 2016 · Journal of Cancer
Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation
Daniele Bergamaschi, Yardena Samuels, Shan Zhong, Xin Lü · 2005 · Oncogene
A site-directed mutagenesis study of the MdmX RING domain
Olga Egorova, Yi Sheng · 2014 · Biochemical and Biophysical Research Communications
Signal Transduction Networks
Frank P. McCormick · 2003 · Humana Press eBooks
p53 Regulation Goes Live--Mdm2 and MdmX Co-Star: Lessons Learned from Mouse Modeling
Laura A. Tollini, Y. Zhang · 2012 · Genes & Cancer
Loss of digestive organ expansion factor (Diexf) reveals an essential role during murine embryonic development that is independent of p53
Neeraj K. Aryal, Amanda R. Wasylishen, Vinod Pant, Maurisa Riley-Croce, Guillermina Lozano · 2017 · Oncotarget
Ubiquitin E3 ligases controlling p53 stability
Seong Won Lee, Min Woo Seong, Young Joo Jeon, Chin Ha Chung · 2012 · Animal Cells and Systems
Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability
Pavlína Doleželová, Kateřina Cetkovská, Karen H. Vousden, Stjepan Uldrijan · 2012 · FEBS Letters
Do p53 stress responses impact organismal aging?
Paul Hasty, Judith Campisi, Zelton Dave Sharp · 2016 · Translational Cancer Research
Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice
Hui Tian, Nicole R. Tackmann, Aiwen Jin, Junnian Zheng, Yanping Zhang · 2017 · Journal of Biological Chemistry
Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Geoffrey M. Wahl, Jayne M. Stommel, Kurt A. Krummel, Mark R. Wade · 2005 · Springer eBooks
Dependence on Mdm2 for Mdm4 inhibition of p53 activity
Shunbin Xiong, Yun Zhang, Xin Zhou, Vinod Pant, Akshita Mirani, Jovanka Gencel‐Augusto, Gilda P. Chau, Mingjian James You, Guillermina Lozano · 2025 · Cancer Letters
Targeting the MDM2 ‐ MDM4 interaction interface reveals an otherwise therapeutically active wild‐type p53 in colorectal cancer
Sonia Valentini, Giada Mele, Marika Attili, Maria Rita Assenza, Fulvio Saccoccia, Francesca Sardina, Cinzia Rinaldo, Roberto Massari, Nicola Tirelli, Alfredo Pontecorvi et al. · 2025 · Molecular Oncology
New developments in small molecules targeting p53 pathways in anticancer therapy
Chit Fang Cheok, David Philip Lane · 2008 · Drug Development Research
A feedback circuit of miR-34a/MDM4/p53 regulates apoptosis in chronic lymphocytic leukemia cells
Lei Cao, Yun Liu, Jinbo Lu, Yi Miao, Xinyi Du, Rong Wang, Hui Yang, Wei Xu, Jianyong Li, Lei Fan · 2020 · Translational Cancer Research
Puma- and Caspase9-mediated apoptosis is dispensable for p53-driven neural crest-based developmental defects
Margot E. Bowen, Abigail S. Mulligan, Aryo Sorayya, Laura Donatella Attardi · 2021 · Cell Death and Differentiation
p53-mediated metabolic response to low doses of ionizing radiation
Isha Nagpal, Zhi-Min Yuan · 2022 · International Journal of Radiation Biology
Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients
Marcus Bauer, Eva Johanna Kantelhardt, Thorsten Stiewe, Andrea Nist, Marco Mernberger, Katharina Politt, Volker Hanf, Tilmann Lantzsch, Christoph Uleer, Susanne Peschel et al. · 2019 · Oncotarget
Combination therapy with p53–MDM2 binding inhibitors for malignancies
Zegao Jin, Jianfeng Shen, Jing-Yao He, Chunqi Hu · 2014 · Medicinal Chemistry Research
Targeting p53 as a Promising Therapeutic Option for Cancer By Re-Activating the Wt Or Mutant p53’s Tumor Suppression
Józefa Węsierska‐Gądek · 2018 · Future Medicinal Chemistry